Sign in

Morgan Stanley MS

Price 211.8 USD
as of 2026-09-03
59/100
Constructive
Quality67
Growth74
Balance-sheet strength45
Valuation42
Momentum70
Income61

Composite 59/100; the shares have moved about 28% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Valuation ranks 42/100 — a slight mark against it.

Case for

Growth ranks 74/100 — a moderate point in its favour. Momentum ranks 70/100 — a moderate point in its favour. Quality ranks 67/100 — a moderate point in its favour.

Case against

Valuation ranks 42/100 — a slight mark against it. Balance-sheet strength ranks 45/100 — a slight mark against it.

What the company does Morgan Stanley provides capital markets, wealth and investment management services across the Americas, EMEA and Asia through three segments: Institutional Securities, Wealth Management and Investment Management.

Key financials ROE 18% and ROA 1.4% indicate strong profitability. Net margin 25.9% and revenue growth 11.5% reflect operational strength. Gross margin 87.6% supports pricing power, while dividend yield 2.1% and payout 33.6% signal shareholder returns.

Stock health Momentum scores are mixed: 12-month 49.77% positive but 6.15% below 52-week high. Sideravia overall 60.8 reflects average quality with positive momentum (77.8). RSI(14) 52.70 suggests neutral technical positioning.

Price vs fair value MS trades at a discount of 9.20% versus the analyst mean target of 236.62. - Morgan Stanley sees gold above $5,000 in 2027 (Barchart) - Dynatrace upgrade cited by Morgan Stanley (Investing.com) - Google AI chip boom could unlock $200B (GuruFocus.com) - Simply Wall St questions if the stock is already fully valued

Looking forward Forward P/E 17.33 and PEG 13.27 suggest moderate valuation. Growth 76.3 and quality 68.3 support a balanced profile, while strength 45.5 and valuation 42.1 indicate room for improvement.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.